Trial Profile

Randomized comparative trial of vonoprazan and esomeplazole in triple therapy for eradication of Helicobacter pylori.

Status: Active, no longer recruiting

Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vonoprazan (Primary) ; Esomeprazole
Indications Helicobacter pylori infections
Focus Therapeutic Use
Acronyms P-CAB; VEHP

Most Recent Events

16 Aug 2019 Planned number of patients changed from 340 to 520.
01 Nov 2017 Results assessing superiority of Vonoprazan Versus Esomeprazole presented at the 25th United European Gastroenterology Week
13 Feb 2017 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com